doi: 10.1016/J.JAUT.2008.01.001 77 GeYPaisieTKNewmanJRBMcIntyreLMConcannonP
biased MC1R agonists for targeted photo-protection
"No-one can legally sell it for human use." The spokesperson said "counterfeit and black market medicines" were untested, unregulated and could be deadly
A health warning on repurposed drugs None of the above should be read to suggest and it is not DW's recommendation that anyone use GLP-1 agonists, or any other drug, to treat any "off label"/non-approved condition, without personal, professional medical advice
As of March 2016 there are 139 studies on PubMed that investigate glutathione levels, and antioxidant and detoxification activity in autism
12,13 Although the original approval was largely based on the potent glucose-dependent insulinotropic properties of GLP-1R activation on pancreatic -cells, it has become clear that the GLP-1R is expressed on a variety of other tissues, which produce a range of biological effects across diverse organ systems (Figure 2)
